2 Stories

Pfizer Pays Record $2.3B Fine for False Marketing

(Newser) - Pfizer will shell out $2.3 billion—a record for a health care fraud settlement—over deceptive marketing of its drugs, the Los Angeles Times reports. Pfizer and one of its subsidiaries marketed four drugs based on off-label uses specifically prohibited by the FDA. The settlement with the Justice Department... More »

New Drug Stirs Debate Over Disease's Existence

Widely advertised Lyrica treats fibromyalgia, but some docs raise red flags

(Newser) - The first drug approved by the FDA to treat fibromyalgia is raising questions, but not the typical ones about whether the medication works. They're questions about whether the disease even exists. Lyrica sales are up and climbing, but critics say giving a name to the chronic pain that characterizes fibromyalgia... More »

2 Stories